For moderate to severe IBS-Constipation
For patients who have not responded adequately to or cannot tolerate all other suitable treatment options BUT BEFORE other agents with higher costs Supported by a RICaD (in development)
For use in men and women for chronic constipation
Supported by a RICaD (in development)